DVA moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 26 of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on DVA as a result. In 62 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for DVA just turned positive on October 05, 2026. Looking at past instances where DVA's MACD turned positive, the stock continued to rise in 24 of 41 cases over the following month. The odds of a continued upward trend are 59%.
The 10-day moving average for DVA crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +6.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where DVA advanced for three days, in 242 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 66 cases where DVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
DVA broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DVA entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. DVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-15.313) is normal, around the industry mean (204.136). P/E Ratio (14.810) is within average values for comparable stocks, (19.375). Projected Growth (PEG Ratio) (0.436) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.098) among similar stocks. P/S Ratio (0.968) is also within normal values, averaging (2.688).
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UHS advanced for three days, in 236 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on UHS as a result. In 67 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for UHS just turned positive on October 14, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 27 of 42 cases over the following month. The odds of a continued upward trend are 64%.
The Aroon Indicator entered an Uptrend today. In 198 of 298 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The 10-day RSI Indicator for UHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 19 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
UHS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.466) is normal, around the industry mean (204.136). P/E Ratio (7.545) is within average values for comparable stocks, (19.375). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.098) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
DVA | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 88 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 51 | 70 | |
SMR RATING 1..100 | 7 | 45 | |
PRICE GROWTH RATING 1..100 | 47 | 45 | |
P/E GROWTH RATING 1..100 | 23 | 77 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UHS's Valuation (65) in the Hospital Or Nursing Management industry is in the same range as DVA (66) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to DVA’s over the last 12 months.
DVA's Profit vs Risk Rating (51) in the Medical Or Nursing Services industry is in the same range as UHS (70) in the Hospital Or Nursing Management industry. This means that DVA’s stock grew similarly to UHS’s over the last 12 months.
DVA's SMR Rating (7) in the Medical Or Nursing Services industry is somewhat better than the same rating for UHS (45) in the Hospital Or Nursing Management industry. This means that DVA’s stock grew somewhat faster than UHS’s over the last 12 months.
UHS's Price Growth Rating (45) in the Hospital Or Nursing Management industry is in the same range as DVA (47) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to DVA’s over the last 12 months.
DVA's P/E Growth Rating (23) in the Medical Or Nursing Services industry is somewhat better than the same rating for UHS (77) in the Hospital Or Nursing Management industry. This means that DVA’s stock grew somewhat faster than UHS’s over the last 12 months.
| DVA | UHS | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 43% |
| Stochastic ODDS (%) | 3 days ago 67% | 3 days ago 56% |
| Momentum ODDS (%) | 3 days ago 72% | 3 days ago 71% |
| MACD ODDS (%) | 3 days ago 59% | 3 days ago 64% |
| TrendWeek ODDS (%) | 3 days ago 58% | 3 days ago 69% |
| TrendMonth ODDS (%) | 3 days ago 67% | 3 days ago 69% |
| Advances ODDS (%) | 4 days ago 69% | 11 days ago 72% |
| Declines ODDS (%) | 6 days ago 55% | 7 days ago 66% |
| BollingerBands ODDS (%) | 3 days ago 64% | 3 days ago 51% |
| Aroon ODDS (%) | 3 days ago 55% | 3 days ago 66% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DVA’s FA Score shows that 2 FA rating(s) are green while UHS’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DVA’s TA Score shows that 5 TA indicator(s) are bullish while UHS’s TA Score has 4 bullish TA indicator(s).
DVA (@Hospital/Nursing Management) experienced а -1.96% price change this week, while UHS (@Hospital/Nursing Management) price change was +0.97% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +2.47%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was +21.91%.
DVA is expected to report earnings on Oct 29, 2026.
UHS is expected to report earnings on Oct 27, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| 1 Day | |||
|---|---|---|---|
| CRYPTO / NAME | Price $ | Chg $ | Chg % |
| BAKE.X | 0.000353 | 0.000003 | +0.93% |
| BakeryToken cryptocurrency | |||
| PSG.X | 0.423898 | 0.002962 | +0.70% |
| Paris Saint-Germain Fan Token cryptocurrency | |||
| PEPE.X | 0.000005 | N/A | -1.19% |
| Pepe cryptocurrency | |||
| MTL.X | 0.270548 | -0.010868 | -3.86% |
| Metal DAO cryptocurrency | |||
| W.X | 0.012293 | -0.000508 | -3.97% |
| Wormhole cryptocurrency | |||
A.I.dvisor tells us that DVA and FMS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DVA and FMS's prices will move in lockstep.
| Ticker / NAME | Correlation To DVA | 1D Price Change % | ||
|---|---|---|---|---|
| DVA | 100% | -1.32% | ||
| FMS - DVA | 33% Poorly correlated | +2.02% | ||
| CON - DVA | 31% Poorly correlated | -1.80% | ||
| PNTG - DVA | 25% Poorly correlated | -0.83% | ||
| ASTH - DVA | 25% Poorly correlated | -1.47% | ||
| UHS - DVA | 23% Poorly correlated | -0.66% | ||
More | ||||
A.I.dvisor indicates that over the last year, UHS has been loosely correlated with HCA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if UHS jumps, then HCA could also see price increases.